Cue Biopharma, Inc.

• Cue Biopharma, Inc. Estimates – NASDAQ:CUE
  TradingView · 23 Oct 2026
• B. Riley sets USD 83 target for Cue Biopharma stock
  AD HOC NEWS · 20 Oct 2026
• Cue Biopharma (CUE) Shareholding Pattern – Promoters, FIIs & DIIs
  Value Research · 16 Oct 2026
• Cue Biopharma (CUE) Slips 2.61% to $18.11 as Shares Pull Back Toward Support - OBV Breakout
  https://www.dars.gov.et/ · 15 Oct 2026
• November 11 earnings are next for Cue Biopharma stock
  AD HOC NEWS · 15 Oct 2026
• Form 4 Cue Biopharma: Shao-Lee Lin (Director, CEO) For: 12 October
  Investing.com India · 15 Oct 2026
• Cue Biopharma CEO Lin Shao-Lee sells $305,490 in shares By Investing.com
  Investing.com Nigeria · 15 Oct 2026
• Cue Biopharma VP Meluzio sells $32,089 in Cue stock for tax
  Investing.com · 14 Oct 2026
• A non-discretionary $51.7K share sale at Cue Biopharma (CUE) would cover stock-grant taxes.
  Stock Titan · 14 Oct 2026
• Cue Biopharma (CUE) Financials – Balance Sheet, Profit & Loss, Cash Flow
  Value Research · 02 Oct 2026
• Cue Biopharma (CUE) Retreats 7.07% to $25.51, Sitting at the Midpoint of Its Recent Range - Covered Call ETF
  https://www.siam.in/ · 30 Sep 2026
• Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria - Slideshow (NASDAQ:CUE) 2026-09-24
  Seeking Alpha · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →